https://capra.ca/ 2025-08-05 1 https://capra.ca/en/advertising/digital-advertising-prospectus 2025-08-27 0.5 https://capra.ca/en/advertising/noc-ads 2026-03-06 0.5 https://capra.ca/en/advertising/e-news-ads 2025-08-27 0.5 https://capra.ca/en/meetings 2026-01-19 0.5 https://capra.ca/en/about-capra/bylaws 2025-10-27 0.5 https://capra.ca/en/about-capra/board-of-directors-and-committee-chairs 2025-10-27 0.5 https://capra.ca/en/advertising 2025-08-27 0.5 https://capra.ca/en/consultants 2025-05-14 0.5 https://capra.ca/en/students 2025-04-30 0.5 https://capra.ca/en/blog 2025-05-13 0.5 https://capra.ca/submissions/forms 2024-06-21 0.5 https://capra.ca/en/search 2024-12-19 0.5 https://capra.ca/en/feedback 2025-10-27 0.5 https://capra.ca/submissions/reviews 2024-06-21 0.5 https://capra.ca/en/cart 2017-05-25 0.5 https://capra.ca/en/user/profile 2025-07-23 0.5 https://capra.ca/en/user/survey 2018-06-21 0.5 https://capra.ca/en/consultants/modify-a-listing 2025-05-14 0.5 https://capra.ca/en/students/faq 2025-04-30 0.5 https://capra.ca/en/feedback/sent 2025-10-27 0.5 https://capra.ca/signin 2025-07-23 0.5 https://capra.ca/en/cart/checkout 2017-05-25 0.5 https://capra.ca/en/cart/pay 2023-04-17 0.5 https://capra.ca/en/cart/confirmation 2017-05-31 0.5 https://capra.ca/en/cart/form 2017-06-13 0.5 https://capra.ca/en/user/profile/success 2025-07-23 0.5 https://capra.ca/en/cart/payments 2023-04-17 0.5 https://capra.ca/en/members/surveys/noc 2018-06-21 0.5 https://capra.ca/en/meetings/submit 2026-01-19 0.5 https://capra.ca/english/photos 2020-05-25 0.5 https://capra.ca/en/blog/welcome-to-regulated-affairs-2017-04-03.htm 2024-10-06 0.5 https://capra.ca/en/blog/changes-to-the-foreign-site-expiry-dates-on-canadian-drug-establishment-licences-2017-04-10.htm 2024-10-06 0.5 https://capra.ca/en/blog/confidential-business-information-disclosure-update-2017-04-17.htm 2024-10-06 0.5 https://capra.ca/en/blog/natural-health-product-research-society-nhprs-of-canada-hosts-14th-annual-conference-beyond-tradition-2017-04-25.htm 2024-10-06 0.5 https://capra.ca/en/blog/the-journey-towards-safe-food-for-canadians-2017-05-01.htm 2024-10-06 0.5 https://capra.ca/en/blog/changes-to-submission-filing-requirements-good-manufacturing-practices-gmpdrug-establishment-licences-del-2017-05-08.htm 2024-10-06 0.5 https://capra.ca/en/blog/future-regulatory-initiative-for-opioids-2017-05-15.htm 2024-10-06 0.5 https://capra.ca/en/blog/annual-drug-notification-form-2017-05-23.htm 2024-10-06 0.5 https://capra.ca/en/blog/information-on-the-new-access-to-cannabis-for-medical-purposes-regulations-2017-05-29.htm 2024-10-06 0.5 https://capra.ca/en/blog/fdas-ectd-mandate-are-you-ready-2017-06-05.htm 2024-10-06 0.5 https://capra.ca/en/blog/changes-to-the-annual-renewal-process-of-canadian-drug-establishment-licences-2017-06-12.htm 2024-10-06 0.5 https://capra.ca/en/blog/a-recap-on-vanessas-law-2017-06-19.htm 2024-10-06 0.5 https://capra.ca/en/blog/canadian-drug-establishment-licences-gmp-requirements-for-api-foreign-building-2017-06-26.htm 2024-10-06 0.5 https://capra.ca/en/blog/ich-good-clinical-practice-renovation-2017-07-05.htm 2024-10-06 0.5 https://capra.ca/en/blog/patients-and-philanderers-why-the-ashley-madison-report-has-something-important-to-say-about-cybersecurity-standards-for-patient-data-2017-07-10.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-begins-consultations-on-mandatory-reporting-by-health-care-institutions-2017-07-17.htm 2024-10-06 0.5 https://capra.ca/en/blog/plain-language-labelling-summary-2017-07-24.htm 2024-10-06 0.5 https://capra.ca/en/blog/an-update-on-the-regulatory-progress-of-biosimilars-in-canada-the-eu-and-the-us-2017-07-31.htm 2024-10-06 0.5 https://capra.ca/en/blog/summary-on-recent-intellectual-property-hold-for-notifiable-change-submissions-2017-08-07.htm 2024-10-06 0.5 https://capra.ca/en/blog/planning-to-file-your-505b2-product-in-canada-2017-08-15.htm 2024-10-06 0.5 https://capra.ca/en/blog/changes-to-the-annual-drug-notification-form-adnf-2017-08-21.htm 2024-10-06 0.5 https://capra.ca/en/blog/comprehensive-economic-and-trade-agreement-ceta-and-canadas-pharmaceutical-sector-2017-08-28.htm 2024-10-06 0.5 https://capra.ca/en/blog/changes-to-the-manufacturers-name-andor-product-name-2017-09-05.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-use-of-certificates-of-suitability-as-supporting-information-in-drug-submissions-2017-09-11.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-proposed-modification-for-multiphasic-modified-release-drugs-2017-09-18.htm 2024-10-06 0.5 https://capra.ca/en/blog/new-health-canada-consultation-on-low-dose-codeine-products-2017-09-25.htm 2024-10-06 0.5 https://capra.ca/en/blog/first-nations-health-authority-fnha-transition-to-bc-pharmacare-2017-10-02.htm 2024-10-06 0.5 https://capra.ca/en/blog/ontario-to-require-public-disclosure-of-industry-payments-to-health-care-professionals-2017-10-10.htm 2024-10-06 0.5 https://capra.ca/en/blog/fda-regulatory-reform-2017-10-16.htm 2024-10-06 0.5 https://capra.ca/en/blog/patented-medicines-notice-of-compliance-regulations-due-to-comprehensive-economic-and-trade-agreement-ceta-2017-10-23.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-guidance-on-fees-for-review-of-submissions-2017-10-30.htm 2024-10-06 0.5 https://capra.ca/en/blog/certificate-of-supplementary-protection-for-pharmaceuticals-biologics-and-veterinary-drugs-2017-11-06.htm 2024-10-06 0.5 https://capra.ca/en/blog/proposed-amendments-to-the-patented-medicines-regulations-2017-11-13.htm 2024-10-06 0.5 https://capra.ca/en/blog/guidance-document-quality-chemistry-and-manufacturing-guidance-new-drug-submissions-ndss-and-abbreviated-new-drug-submissions-andss-2017-11-20.htm 2024-10-06 0.5 https://capra.ca/en/blog/toward-a-strengthened-assisted-human-reproduction-act-2017-11-27.htm 2024-10-06 0.5 https://capra.ca/en/blog/new-guidance-document-use-of-a-foreign-sourced-reference-product-as-a-canadian-reference-product-2017-12-04.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-proposed-cannabis-regulatory-framework-2017-12-11.htm 2024-10-06 0.5 https://capra.ca/en/blog/ich-publishes-new-guidance-on-pediatric-clinical-trials-and-genomic-data-2017-12-21.htm 2024-10-06 0.5 https://capra.ca/en/blog/the-acss-australia-canada-singapore-switzerland-consortium-and-the-generic-medicines-work-sharing-trial-2018-01-08.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-notice-on-the-medical-device-single-audit-program-2018-01-22.htm 2024-10-06 0.5 https://capra.ca/en/blog/guidance-document-guidance-for-manufacturers-of-human-immunodeficiency-virus-hiv-rapid-diagnostic-tests-rdts-for-use-at-the-point-of-care-or-for-self-testing-2018-01-29.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-guidance-on-applications-for-medical-device-investigational-testing-authorizations-2018-02-05.htm 2024-10-06 0.5 https://capra.ca/en/blog/validation-rules-for-regulatory-transactions-submitted-in-the-electronic-common-technical-document-ectd-format-1970-01-01.htm 2024-10-06 0.5 https://capra.ca/en/blog/validation-rules-for-regulatory-transactions-submitted-in-the-electronic-common-technical-document-ectd-format-2018-02-20.htm 2024-10-06 0.5 https://capra.ca/en/blog/pan-canadian-pharmaceutical-alliance-for-generic-drugs-2018-02-26.htm 2024-10-06 0.5 https://capra.ca/en/blog/ich-draft-on-technical-and-regulatory-considerations-for-pharmaceutical-product-lifecycle-management-q12-2018-03-05.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-sector-payment-transparency-act-2017-new-regulation-2018-03-12.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-adoption-of-ich-m7-2018-03-20.htm 2024-10-06 0.5 https://capra.ca/en/blog/regulatory-enrollment-process-and-the-use-of-the-common-electronic-submission-gateway-for-medical-devices-2018-04-02.htm 2024-10-06 0.5 https://capra.ca/en/blog/cadth-revisions-to-the-biosimilar-review-process-and-resubmission-2018-04-11.htm 2024-10-06 0.5 https://capra.ca/en/blog/administrative-processing-of-submissions-and-applications-human-or-disinfectant-drugs-2018-04-18.htm 2024-10-06 0.5 https://capra.ca/en/blog/the-australia-canada-singapore-switzerland-acss-consortium-2018-04-23.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-guideline-for-residual-solvents-2018-05-02.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-notice-on-ich-selection-and-justification-of-starting-materials-for-the-manufacture-of-drug-substances-2018-05-09.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-continues-to-tweak-requirements-for-mdsap-transition-2018-05-14.htm 2024-10-06 0.5 https://capra.ca/en/blog/release-of-proposed-imdrf-document-definitions-for-personalized-medical-devices-2018-05-23.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-adapts-to-digital-health-technologies-2018-05-29.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-implements-ich-guidance-e11r1-addendum-clinical-investigation-of-medicinal-products-in-the-pediatric-population-2018-06-06.htm 2024-10-06 0.5 https://capra.ca/en/blog/medical-device-single-audit-program-reduction-of-audit-times-for-small-sized-enterprises-update-2018-06-12.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-notice-on-ectd-submission-of-master-files-2018-06-19.htm 2024-10-06 0.5 https://capra.ca/en/blog/australia-canada-singapore-switzerland-acss-consortium-new-chemical-entities-work-sharing-trial-phase-i-2018-06-27.htm 2024-10-06 0.5 https://capra.ca/en/blog/final-notice-classification-of-dental-plaque-disclosing-products-as-drugs-2018-07-09.htm 2024-10-06 0.5 https://capra.ca/en/blog/consultation-on-prescription-drug-transparency-2018-07-19.htm 2024-10-06 0.5 https://capra.ca/en/blog/ich-e18-genomic-sampling-and-management-of-genomic-data-2018-07-23.htm 2024-10-06 0.5 https://capra.ca/en/blog/antimicrobial-resistance-and-health-canadas-pathogens-of-interest-list-2018-08-02.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-transition-to-global-medical-device-nomenclature-2018-08-09.htm 2024-10-06 0.5 https://capra.ca/en/blog/strengthening-post-market-surveillance-and-risk-management-of-medical-devices-in-canada-2018-08-20.htm 2024-10-06 0.5 https://capra.ca/en/blog/guidance-on-notifying-health-canada-of-foreign-actions-2018-08-27.htm 2024-10-06 0.5 https://capra.ca/en/blog/vanessas-law-taking-a-first-look-2018-09-10.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-plan-to-phase-out-most-uses-of-clothianidin-and-thiamethoxam-2018-09-18.htm 2024-10-06 0.5 https://capra.ca/en/blog/certificate-of-supplementary-protection-csp-updated-guidance-2018-09-25.htm 2024-10-06 0.5 https://capra.ca/en/blog/upcoming-guidance-development-on-the-licensing-requirements-for-3d-printed-devices-2018-10-09.htm 2024-10-06 0.5 https://capra.ca/en/blog/the-long-awaited-legalization-of-cannabis-in-canada-2018-10-16.htm 2024-10-06 0.5 https://capra.ca/en/blog/toward-global-harmonization-health-canada-to-adopt-imdrf-table-of-contents-format-for-class-iii-and-iv-applications-2018-10-22.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-update-on-investigational-testing-authorizations-for-medical-devices-2018-10-29.htm 2024-10-06 0.5 https://capra.ca/en/blog/device-advice-health-canada-launching-a-new-pilot-project-to-formalize-regulatory-advice-framework-for-medical-device-manufacturers-2018-11-06.htm 2024-10-06 0.5 https://capra.ca/en/blog/software-as-medical-devices-samd-where-to-go-from-here-2018-11-16.htm 2024-10-06 0.5 https://capra.ca/en/blog/proposed-amendments-to-regulations-under-the-ontario-drug-benefit-act-and-the-drug-interchangeability-and-dispensing-fee-act-2018-11-26.htm 2024-10-06 0.5 https://capra.ca/en/blog/cybersecurity-draft-guidance-document-2019-01-04.htm 2024-10-06 0.5 https://capra.ca/en/blog/post-noc-level-iii-change-updates-2019-01-07.htm 2024-10-06 0.5 https://capra.ca/en/blog/summary-of-annual-trends-of-adverse-reaction-case-reports-submitted-to-health-canada-2019-02-05.htm 2024-10-06 0.5 https://capra.ca/en/blog/improving-safety-effectiveness-and-quality-the-medical-device-action-plan-2019-02-13.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-requests-feedback-on-potential-impacts-and-uses-if-company-names-were-added-to-the-generic-submissions-under-review-list-2019-02-25.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-assessment-suggests-that-talc-may-be-harmful-to-human-health-2019-03-04.htm 2024-10-06 0.5 https://capra.ca/en/blog/canadian-cannabis-survey-2018-2019-03-12.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-notice-on-the-discontinuation-of-acknowledgement-letters-for-regulatory-activities-2019-03-27.htm 2024-10-06 0.5 https://capra.ca/en/blog/release-of-draft-guidance-document-regulatory-requirements-for-drug-identification-numbers-dins-2019-04-08.htm 2024-10-06 0.5 https://capra.ca/en/blog/guidance-document-regarding-administrative-processing-of-submissions-and-applications-human-or-disinfectant-drugs-2019-04-23.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-getting-tougher-on-opioid-and-illegal-advertising-2019-04-29.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-scanning-and-consultations-on-whats-next-for-health-product-regulation-2019-05-06.htm 2024-10-06 0.5 https://capra.ca/en/blog/improving-access-to-clinical-data-2019-05-27.htm 2024-10-06 0.5 https://capra.ca/en/blog/special-access-program-draft-guidance-2019-06-18.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-notice-on-ich-q3d-r1-the-guideline-for-elemental-impurities-2019-07-03.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-drug-and-medical-device-highlights-2018-2019-07-15.htm 2024-10-06 0.5 https://capra.ca/en/blog/regulatory-enrolment-process-rep-pilot-for-clinical-trials-2019-10-15.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-issues-important-safety-information-for-ranitidine-products-2019-11-04.htm 2024-10-06 0.5 https://capra.ca/en/blog/biosimilar-pharmaceuticals-in-canada-fact-sheet-2019-11-13.htm 2024-10-06 0.5 https://capra.ca/en/blog/changes-to-the-cosmetic-ingredient-hotlist-2019-12-20.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-collaborates-with-us-and-australian-regulators-through-project-orbis-a-framework-for-concurrent-review-of-oncology-products-2020-01-10.htm 2024-10-06 0.5 https://capra.ca/en/blog/cost-recovery-fees-in-respect-of-drugs-and-medical-devices-2020-01-20.htm 2024-10-06 0.5 https://capra.ca/en/blog/software-as-a-medical-device-samd-definition-and-classification-2020-01-27.htm 2024-10-06 0.5 https://capra.ca/en/blog/canadian-product-monograph-upcoming-changes-implementation-timeline-2020-02-03.htm 2024-10-06 0.5 https://capra.ca/en/blog/the-emerging-viral-pathogen-2019-ncov-coronavirus-and-what-it-means-for-broad-spectrum-virucide-disinfectants-2020-02-10.htm 2024-10-06 0.5 https://capra.ca/en/blog/information-on-nitrosamine-impurity-2020-02-18.htm 2024-10-06 0.5 https://capra.ca/en/blog/clinical-trial-regulatory-activities-in-ectd-2020-03-02.htm 2024-10-06 0.5 https://capra.ca/en/blog/paab-update-on-digitization-of-advertising-promotional-systems-aps-2020-03-18.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canadas-interim-expedited-licensing-approach-for-the-production-and-distribution-of-alcohol-based-hand-sanitizers-2020-04-01.htm 2024-10-06 0.5 https://capra.ca/en/blog/regulatory-enrolment-process-mandatory-effective-october-1-2020-2020-04-06.htm 2024-10-06 0.5 https://capra.ca/en/blog/the-ever-changing-hard-surface-disinfectant-landscape-in-covid-19-times-2020-04-14.htm 2024-10-06 0.5 https://capra.ca/en/blog/health-canada-notice-management-of-clinical-trials-during-covid-19-2020-04-27.htm 2024-10-06 0.5 https://capra.ca/en/blog/distribution-of-low-risk-dinnpn-products-as-samples-2020-05-04.htm 2024-10-06 0.5 https://capra.ca/en/blog/interim-labelling-of-products-during-covid-19-hand-sanitizers-disinfectants-soaps-and-cleaning-products-2020-05-19.htm 2024-10-06 0.5 https://capra.ca/en/blog/interim-order-to-facilitate-covid-19-clinical-trials-related-to-drugs-and-medical-device-2020-06-05.htm 2024-10-06 0.5 https://capra.ca/en/blog/an-update-from-nnhpd-release-of-new-web-pla-form-version-4-2020-06-22.htm 2024-10-06 0.5 https://capra.ca/en/blog/step-2b-draft-q3cr8-impurities-guideline-for-residual-solvents-released-for-public-consultation-2020-07-06.htm 2024-10-06 0.5 https://capra.ca/en/blog/non-medical-masks-or-face-coverings-regulatory-considerations-in-the-context-of-covid-19-2020-08-03.htm 2024-10-06 0.5 https://capra.ca/en/blog/drug-reimbursement-aligned-review-process-by-cadth-2020-10-14.htm 2024-10-06 0.5 https://capra.ca/en/blog/how-health-canadas-draft-guidance-on-electronic-media-in-prescription-drug-labelling-may-affect-drug-advertising-2021-04-16.htm 2024-10-06 0.5 https://capra.ca/en/blog/amendments-to-the-food-and-drug-regulations-to-replace-the-interim-order-respecting-the-importation-sale-and-advertising-of-drugs-for-use-in-relation-to-covid-19-isad-io-2021-04-29.htm 2024-10-06 0.5 https://capra.ca/en/blog/interim-order-no-2-respecting-clinical-trials-for-medical-devices-and-drugs-relating-to-covid-19-2021-06-30 2024-10-06 0.5 https://capra.ca/committees.html 2026-02-23 0.5 https://capra.ca/en/blog/health-canadas-proposal-for-clinical-trials-regulatory-modernization-2021-07-16 2024-10-06 0.5 https://capra.ca/en/blog/hc-mhra-guideline-increasing-transparency-when-presenting-safety-information-in-the-dsur-2021-08-16 2024-10-06 0.5 https://capra.ca/members/committees/media 2021-09-14 0.5 https://capra.ca/en/meetings/webinar-the-evolving-us-regulatory-environment-major-takeaways-from-2019-2020-04-09.htm 2021-09-14 0.5 https://capra.ca/en/meetings/webinar-health-canada-gmp-inspections-clinical-trials-during-covid-19-2020-06-11.htm 2021-09-14 0.5 https://capra.ca/en/meetings/virtual-education-day-2020-2020-07-07.htm 2021-09-14 0.5 https://capra.ca/en/meetings/webinar-health-canada-gvp-inspections-of-foreign-marketing-authorisation-holders-2020-07-28.htm 2021-09-14 0.5 https://capra.ca/en/meetings/introduction-to-health-product-advertising-2020-08-19.htm 2021-09-14 0.5 https://capra.ca/en/meetings/capra-annual-general-meeting-2020-11-25.htm 2021-09-14 0.5 https://capra.ca/en/meetings/webinar-new-pmprb-guidelines-impact-on-drug-pricing-in-canada-2020-11-25.htm 2021-09-14 0.5 https://capra.ca/en/meetings/health-canada-regulatory-and-clinical-modernization-initiatives-virtual-workshops-2021-05-18.htm 2021-09-14 0.5 https://capra.ca/en/meetings/capra-virtual-education-day-2021-2021-06-08.htm 2021-09-14 0.5 https://capra.ca/en/meetings/webinar-modernization-and-accessibility-of-clinical-research-by-implementing-decentralized-clinical-trials-as-a-care-option-for-participants-2021-07-13.htm 2021-09-14 0.5 https://capra.ca/en/meetings/audiopresentations-now-available-for-capra-education-day-2021-2021-07-30.htm 2021-09-14 0.5 https://capra.ca/en/meetings/labelling-symposium-with-health-canada-2021-12-07 2021-12-07 0.5 https://capra.ca/en/blog/health-canada-draft-revised-guidance-documents-on-post-noc-changes-quality-for-consultation-2021-09-30 2024-10-06 0.5 https://capra.ca/en/meetings/capra-annual-general-meeting-2021-11-24 2021-11-24 0.5 https://capra.ca/en/meetings/webinar-drug-establishment-licencing-an-industry-perspective-2021-11-24_1 2021-11-24 0.5 https://capra.ca/en/blog/to-distribute-or-not-to-distribute-health-canadas-guide-to-distributing-drugs-intended-for-the-canadian-market-for-consumption-or-use-outside-canada-2021-11-17 2024-10-06 0.5 https://capra.ca/en/about 2025-10-27 0.5 https://capra.ca/en/meetings/2022-capra-symposium-public-release-of-clinical-information-2022-03-07_1 2022-11-18 0.5 https://capra.ca/en/blog/fdas-new-annual-distribution-reporting-requirement-under-section-510j3-of-the-fdc-act-for-reporting-the-amount-of-commercially-distributed-listed-drugs-and-biological-products-2022-02-14 2024-10-06 0.5 https://capra.ca/en/blog/biosimilars-and-their-approval-in-canada-2022-03-22 2024-10-06 0.5 https://capra.ca/en/meetings/webinar-introduction-to-the-food-and-drugs-act-liaison-office-and-an-overview-of-the-reconsideration-process-2022-04-28 2022-04-05 0.5 https://capra.ca/en/meetings/capra-education-day-2022-2022-06-01 2022-06-13 0.5 https://capra.ca/en/blog/real-world-dataevidence-increasing-use-in-healthcare-for-regulatory-decision-making-2022-04-29 2024-10-06 0.5 https://capra.ca/en/blog/the-need-for-regulatory-innovation-in-canada-a-series-issue-1-2022-05-06 2024-10-06 0.5 https://capra.ca/en/blog/digital-therapeutics-reshaping-the-future-of-medicine-2022-05-13 2024-10-06 0.5 https://capra.ca/en/blog/3d-printing-our-way-to-better-health-care-2022-06-27 2024-10-06 0.5 https://capra.ca/en/blog/the-fda-announces-proposed-rule-nonprescription-drug-product-with-an-additional-condition-for-nonprescription-use-june-28-2022-2022-07-19 2024-10-06 0.5 https://capra.ca/en/meetings/webinar-health-canada-psychedelic-restricted-drugs-legal-access-pathways-2022-08-18 2022-08-15 0.5 https://capra.ca/en/blog/pragmatic-clinical-trials-testing-treatments-in-the-real-world-2022-10-17 2024-10-06 0.5 https://capra.ca/en/meetings/understanding-ich-q12-regulatory-and-technical-considerations-to-manage-post-approval-changes-2023-01-17 2023-01-13 0.5 https://capra.ca/en/meetings/capra-annual-general-meeting-2002-11-30 2022-11-07 0.5 https://capra.ca/en/meetings/capra-annual-general-meeting-2022-11-30 2022-11-29 0.5 https://capra.ca/en/meetings/online-webinar-cannabis-health-products-the-current-landscape-and-approaching-market-opportunities-2022-12-07 2022-11-15 0.5 https://capra.ca/en/consultants/goldman-regulatory-compliance-innovavet 2025-01-30 0.5 https://capra.ca/en/meetings/electronic-regulatory-landscape-current-trends-and-upcoming-opportunities-2023-06-01 2023-06-05 0.5 https://capra.ca/en/meetings/capra-education-day-2023-2023-05-11 2023-05-17 0.5 https://capra.ca/en/blog/health-canada-changes-filing-requirements-for-product-monographs-2023-04-10 2024-10-06 0.5 https://capra.ca/en/consultants/pharma-4u 2025-04-15 0.5 https://capra.ca/en/blog/rare-diseases-and-orphan-drugs-regulatory-framework-in-canada-recent-initiatives-by-government-of-canada-2023-05-15 2024-10-06 0.5 https://capra.ca/en/meetings/online-webinar-the-evolving-regulatory-landscape-of-therapies-using-a-patients-own-stem-cells-the-patient-perspective-2023-10-05 2023-09-07 0.5 https://capra.ca/en/blog/technology-continues-to-transform-healthcare-and-the-regulatory-world-2023-09-15 2024-10-06 0.5 https://capra.ca/en/meetings/montreal-dinner-meeting-2023-10-12 2023-10-06 0.5 https://capra.ca/en/meetings/online-webinar-the-medical-devices-compliance-program-2023-10-24 2023-10-10 0.5 https://capra.ca/en/meetings/capra-annual-general-meeting-2023-11-01 2023-10-19 0.5 https://capra.ca/en/blog/artificial-intelligence-revolutionizing-the-healthcare-industry-2023-10-27 2024-10-06 0.5 https://capra.ca/en/meetings/online-webinar-continuing-to-work-towards-the-self-care-framework-presentation-by-the-natural-and-non-prescription-health-products-directorate-nnhpd-2023-12-12 2024-02-16 0.5 https://capra.ca/en/consultants/stan-north-consultation-2023-12-04 2025-03-04 0.5 https://capra.ca/en/consultants/mcs-associates-division-of-reena-group-of-companies-inc-2023-12-08 2025-07-21 0.5 https://capra.ca/en/consultants/pharmaffair-2023-12-14 2025-01-27 0.5 https://capra.ca/en/meetings/montreal-dinner-meeting-2024-01-30 2024-02-08 0.5 https://capra.ca/en/consultants/nucro-technics 2025-01-27 0.5 https://capra.ca/en/consultants/gilberts-llp 2025-01-29 0.5 https://capra.ca/en/consultants/regxia-inc-2024-01-18 2025-01-24 0.5 https://capra.ca/en/meetings/toronto-dinner-meeting-2024-02-15 2024-02-15 0.5 https://capra.ca/en/consultants/stelioz-solutions-inc 2026-03-26 0.5 https://capra.ca/en/consultants/canadex-labs 2026-01-14 0.5 https://capra.ca/en/meetings/online-webinar-overview-of-the-regulatory-framework-for-cosmetics-and-recent-updates-2024-03-20 2024-02-21 0.5 https://capra.ca/en/meetings/online-webinar-safe-food-for-canadians-regulations-sfrc-2024-04-16 2024-03-22 0.5 https://capra.ca/en/meetings/capra-annual-education-day-2024-06-05 2024-05-31 0.5 https://capra.ca/en/meetings/toronto-dinner-meeting-2024-05-15 2024-05-03 0.5 https://capra.ca/en/meetings/montreal-dinner-meeting-2024-06-12 2024-06-10 0.5 https://capra.ca/en/meetings/capra-symposium2024-2024-10-22 2024-10-29 0.5 https://capra.ca/membership-2-1 2026-03-12 0.5 https://capra.ca/en/blog/virtual-healthcare-in-canada-2024-07-03 2024-10-06 0.5 https://capra.ca/membership/group-renewal 2026-03-12 0.5 https://capra.ca/membership-2-1/join-component 2026-03-12 0.5 https://capra.ca/membership-2-1/publications 2026-03-12 0.5 https://capra.ca/join 2026-03-12 0.5 https://capra.ca/en/meetings/online-free-webinar-regulatory-modernization-of-foods-for-special-dietary-use-and-infant-foods-from-health-canadas-bureau-of-nutritional-sciences-2024-07-31 2024-07-22 0.5 https://capra.ca/en/blog/addressing-underrepresentation-in-clinical-trials-fdas-diversity-action-plan-2024-07-30 2024-10-06 0.5 https://capra.ca/en/blog/value-based-drug-pricing-in-canada-and-its-limitations-2024-08-14 2024-10-20 0.5 https://capra.ca/en/blog/rethinking-cost-sharing-the-need-for-health-insurance-reform-in-the-us-2024-09-15 2024-10-06 0.5 https://capra.ca/en/meetings/webinarveterinary-drugs-regulating-101-2024-10-30 2025-04-09 0.5 https://capra.ca/guides 2024-10-16 0.5 https://capra.ca/en/meetings/2024-agm-meeting 2026-01-19 0.5 https://capra.ca/agm-dinner-meeting-2024-11-06 2025-05-15 0.5 https://capra.ca/en/meetings/capra-2024-pharmaceutical-symposium-post-event 2026-01-19 0.5 https://capra.ca/en/meetings/montreal-dinner-meeting-november-2024 2026-01-19 0.5 https://capra.ca/en/meetings/montreal-dinner-meeting-2024-11-26 2025-05-15 0.5 https://capra.ca/en/meetings/capra-2025-biologicsbiosimilar-symposium-1 2026-01-19 0.5 https://capra.ca/consultants-share-your-expertise-network 2026-01-28 0.5 https://capra.ca/en/consultants/vg-solutions-inc-2024-12-31 2024-12-31 0.5 https://capra.ca/en/consultants/innovia-biopharma-2025-01-24 2025-01-24 0.5 https://capra.ca/en/consultants/redstone-health-group-inc-2025-01-24 2025-01-24 0.5 https://capra.ca/en/consultants/aaps-pharma 2025-01-31 0.5 https://capra.ca/en/consultants/nucro-technics-inc-2025-02-02 2025-02-02 0.5 https://capra.ca/en/consultants/pharmaknowl 2025-09-09 0.5 https://capra.ca/en/consultants/regulatory-unboxed-2025-02-04 2025-02-04 0.5 https://capra.ca/en/consultants/qr-canada-inc-2025-02-04 2025-02-04 0.5 https://capra.ca/en/consultants/lezayre-e-submissions-ltd 2025-02-07 0.5 https://capra.ca/en/consultants/blaney-mcmurtry-llp-2025-02-24 2025-02-24 0.5 https://capra.ca/en/consultants/lebelpharma-inc-2 2025-02-26 0.5 https://capra.ca/en/consultants/manage 2026-01-28 0.5 https://capra.ca/en/consultants/integrated-therapeutic-solutions-inc-2025-02-27 2025-02-27 0.5 https://capra.ca/en/meetings/capra-2025-biologics-and-biosimilar-resources 2026-01-19 0.5 https://capra.ca/en/consultants/axsource-consulting-inc-2025-03-18 2025-03-18 0.5 https://capra.ca/en/meetings/capra-education-day-2025 2026-04-02 0.5 https://capra.ca/en/meetings/capra-hybrid-annual-education-day-2025-2025-06-17 2025-10-27 0.5 https://capra.ca/en/meetings/regulatory-and-quality-updated-impacting-medical-devices-2025-05-06 2025-10-27 0.5 https://capra.ca/en/meetings/free_webinar_05-06-2025 2026-01-19 0.5 https://capra.ca/en/consultants/fsq-experts-north-america-2025-04-13 2025-04-13 0.5 https://capra.ca/en/consultants/inglobe-solutions-ltd-1 2025-04-24 0.5 https://capra.ca/en/blog/insights-from-11-years-of-good-clinical-practice-gcp-inspections-2025-05-13-1 2025-05-13 0.5 https://capra.ca/en/consultants/add-listing 2026-01-28 0.5 https://capra.ca/en/meetings/montreal-dinner-meeting-2025-07-09 2025-10-27 0.5 https://capra.ca/en/meetings/june-26-2025-capra-toronto-dinner-meeting 2026-01-19 0.5 https://capra.ca/en/meetings/july-09-2025-capra-montreal-dinner-meeting 2026-01-19 0.5 https://capra.ca/en/meetings/toronto-dinner-meeting-2025-06-26 2025-10-27 0.5 https://capra.ca/en/consultants/icon-regulatory-consulting-solutions-2025-06-05 2025-06-05 0.5 https://capra.ca/en/consultants/president-2025-06-10 2025-06-10 0.5 https://capra.ca/en/meetings/capra-annual-education-day-2025-post-event-resources 2026-01-19 0.5 https://capra.ca/en/advertising/careers 2025-08-27 0.5 https://capra.ca/en/advertising/submit-your-career 2025-08-27 0.5 https://capra.ca/en/blog/precision-healthcare-powered-by-artificial-intelligence-a-global-regulatory-perspective-2025-06-01-1 2025-07-02 0.5 https://capra.ca/en/meetings/webinar-cannabis-related-products-developing-therapeutics-in-an-evolving-legalregulatory-landscape-2025-07-29 2026-03-04 0.5 https://capra.ca/en/meetings/free-webinar-july-29-2025 2026-02-26 0.5 https://capra.ca/en/consultants/innovative-regulatory-inc 2025-07-18 0.5 https://capra.ca/en/consultants/standpoint-health-research 2025-09-16 0.5 https://capra.ca/faqs 2025-08-05 0.5 https://capra.ca/en/meetings/medical-device-and-combination-product-2025-12-03 2026-01-21 0.5 https://capra.ca/caprasymposiummedicaldeviceandombinationproduct 2026-01-19 0.5 https://capra.ca/en/meetings/toronto-dinner-meeting-2025-09-09 2025-10-27 0.5 https://capra.ca/en/meetings/montreal-dinner-meeting-2025-09-23 2025-10-27 0.5 https://capra.ca/090925tdm 2026-01-19 0.5 https://capra.ca/23092025mdm 2026-01-19 0.5 https://capra.ca/en/consultants/president-2025-08-19 2025-08-19 0.5 https://capra.ca/en/consultants/intrinsik-corp 2025-09-19 0.5 https://capra.ca/en/consultants/innomar-strategies-inc-2025-09-22 2025-09-22 0.5 https://capra.ca/en/consultants/claropv-services-inc 2025-09-29 0.5 https://capra.ca/en/consultants/regmedical-inc-1 2025-10-08 0.5 https://capra.ca/en/meetings/webinar-drug-shortages-detection-through-to-mitigation-2025-11-03 2026-03-04 0.5 https://capra.ca/en/meetings/2025-agm-2025-11-18 2025-11-20 0.5 https://capra.ca/agm2025 2026-01-19 0.5 https://capra.ca/en/consultants/globyz-biopharma-services 2025-11-28 0.5 https://capra.ca/en/meetings/pre-event-resources-capra-2025-medical-device-and-combination-product---dec-03-2025 2026-01-19 0.5 https://capra.ca/en/consultants/amosey-inc-3 2025-12-06 0.5 https://capra.ca/en/consultants/pasb-medtech-solutions 2026-01-02 0.5 https://capra.ca/tdm02182026 2026-02-23 0.5 https://capra.ca/030526mdm 2026-03-10 0.5 https://capra.ca/en/consultants/oakls 2026-02-03 0.5 https://capra.ca/en/meetings/webinar-regulatory-professional-career-development-2026-04-01 2026-03-04 0.5 https://capra.ca/freewebinar04012026 2026-04-02 0.5 https://capra.ca/en/meetings/free-webinar-nov-03-2025 2026-02-26 0.5 https://capra.ca/en/consultants/intertek-assuris 2026-03-05 0.5 https://capra.ca/en/consultants/focal-point-research-inc-2 2026-03-05 0.5 https://capra.ca/eday052726 2026-04-02 0.5 https://capra.ca/en/meetings/capra-hybrid-annual-education-day-2026-2026-05-27 2026-03-13 0.5 https://capra.ca/en/consultants/pharmakon-consultants 2026-03-23 0.5